Check patentability & draft patents in minutes with Patsnap Eureka AI!

Eplerenone solvate and preparation method thereof

A technology of eplerenone and solvate, applied in the field of pharmaceutical preparation, can solve the problems of failing to meet pharmacopoeia standards, large loss of raw materials and solvents, large solvent residues, etc., and achieves good impurity removal effect, small solvent residues, The effect of improving purity

Pending Publication Date: 2018-05-22
HEFEI JIUNUO MEDICAL TECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing solvent crystallization technology has poor selectivity for eplerenone impurities, requires repeated refining with different solvents, large loss of raw materials and solvents, high cost, low yield, and the desolvation temperature is higher than 100°C, drying can High consumption, high equipment requirements, large amount of solvent residue, can not meet the current pharmacopoeia standard

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eplerenone solvate and preparation method thereof
  • Eplerenone solvate and preparation method thereof
  • Eplerenone solvate and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] According to Example 26 (page 139) of patent EP1223174, the oxidation reaction is completed, and the reaction solution is washed and concentrated to dryness to obtain a primary synthetic product of eplerenone with a purity of 86.12%.

[0040] A preparation method of eplerenone solvate, comprising the steps of: adding 500 g of the primary synthetic eplerenone into 5 L of 1,4-dioxane, heating to 90° C., stirring for 0.5 h, and cooling to 0°C, filter, and dry the filter cake at 80°C for 3 hours to obtain 510 g of eplerenone solvate containing 16.83% 1,4-dioxane, with a yield of 84.8% and a purity of 98.77%.

[0041] A preparation method for L crystal form eplerenone, comprising the following steps: drying 500 g of 1,4-dioxane solvate at 100° C. for 6 hours to obtain 415.5 g of L crystal form eplerenone with a purity of 98.77 %.

Embodiment 2

[0043] According to Example 26 (page 139) of patent EP1223174, the oxidation reaction is completed, and the reaction solution is washed and concentrated to dryness to obtain a primary synthetic product of eplerenone with a purity of 85.27%.

[0044] A preparation method of eplerenone solvate, comprising the steps of: adding 50 g of eplerenone primary synthetic product to 750 ml of water / 1,4-dioxane (3 / 10, v / v) mixed solvent , heated to 60°C, stirred for 2 hours, cooled to 20°C, stirred and crystallized for 2 hours, filtered, and the filter cake was dried under reduced pressure at 40°C for 6 hours to obtain eplerenone containing 15.47% 1,4-dioxane The solvate was 50g, the yield was 84.5.0%, and the purity was 98.45%.

[0045] A preparation method of L crystal form eplerenone, comprising the following steps: drying 45 g of 1,4-dioxane solvate at 95° C. for 4 hours under reduced pressure to obtain 38 g of L crystal form eplerenone, with a purity of is 98.45%.

Embodiment 3

[0047] According to Example 26 (page 139) of patent EP1223174, the oxidation reaction is completed, and the reaction solution is washed and concentrated to dryness to obtain a primary synthetic product of eplerenone with a purity of 85.58%.

[0048]A preparation method of eplerenone solvate, comprising the steps of: adding 500 g of eplerenone primary synthetic product to 4L of ethanol / 1,4-dioxane (1 / 10, v / v) and mixing In a solvent, heat to 75°C, stir for 1h, cool down to 10°C, stir and crystallize for 1h, filter, and dry the filter cake at 60°C for 4h under reduced pressure to obtain Epril containing 14.55% 1,4-dioxane Ketone solvate 502.5g, yield 85.9%, purity 98.54%. .

[0049] A preparation method of L crystal form eplerenone, comprising the following steps: drying 500 g of 1,4-dioxane solvate at 100° C. for 3 hours under reduced pressure to obtain 422.2 g of L crystal form eplerenone, 98.54% purity.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses eplerenone solvate, and further discloses a preparation method of the eplerenone solvate. The method comprises the following steps of adding an eplerenone crude product into a1,4-dioxane solvent system, heating, stirring, cooling to crystallize, filtering, and drying to prepare eplerenone 1,4-dioxane solvate. The invention further discloses a preparation method of L crystal form eplerenone, and the method comprises the following step of enabling the eplerenone solvate to be subjected to normal pressure or reduced pressure drying to exsolve to prepare the L crystal formeplerenone. According to the eplerenone solvate, the preparation process is simple and convenient, the energy consumption is low, the yield of prepared products is high, the impurity removing effectis good, and the application prospect is broad.

Description

technical field [0001] The invention relates to the technical field of medicine preparation, in particular to an eplerenone solvate and a preparation method thereof. Background technique [0002] Eplerenone (Eplerenone, I), chemical name 9α, 11α-epoxy-17β-hydroxy-3-oxo-17α-pregna-4-ene-7α, 21-dicarboxylic acid, γ-lactone , 7-methyl ester, the chemical structural formula is the following formula I: [0003] Eplerenone is an antihypertensive drug. It is mainly used to treat essential hypertension and heart failure after myocardial infarction. Its mechanism of action is to block aldosterone in the renin-angiotensin-aldosterone system by binding to aldosterone receptors, thereby lowering blood pressure. Developed by U.S. Pfizer company, eplerenone tablet (trade name: 25mg, 50mg) were first launched in the United States in 2002, and are mainly used clinically for the treatment of hypertension, heart failure and myocardial infarction. [0004] The synthesis route of eplerenon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07J71/00
CPCC07B2200/13C07J71/0015
Inventor 吴标凌林佘文龙唐胜国张严金
Owner HEFEI JIUNUO MEDICAL TECH
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More